Table 2.
Variable | Treatment Method N=150 | P value | |||||||
---|---|---|---|---|---|---|---|---|---|
BCT N=50 | MTX N=50 | MTX+R N=50 | |||||||
n | % | n | % | n | % | n | % | ||
Duration of illness | |||||||||
Up to 2 years | 68 | 45% | 21 | 42% | 19 | 38% | 28 | 56% | 0.001 |
2–5 years | 34 | 23% | 11 | 22% | 7 | 14% | 16 | 32% | |
More than 5 years | 46 | 31% | 18 | 36% | 23 | 46% | 5 | 10% | |
No answer | 2 | 1% | 0 | 0% | 1 | 2% | 1 | 2% | |
Treatment forms* | |||||||||
Surgery | 141 | 94% | 43 | 86% | 48 | 96% | 50 | 100% | 0.011 |
Chemotherapy | 112 | 75% | 28 | 56% | 47 | 94% | 37 | 74% | <0.001 |
Radiation therapy | 90 | 60% | 46 | 92% | 32 | 64% | 12 | 24% | <0.001 |
Hormonal therapy | 79 | 53% | 28 | 56% | 19 | 38% | 32 | 64% | 0.029 |
The most significant complaint associated with the disease* | |||||||||
Pain | 72 | 48% | 20 | 40% | 23 | 46% | 29 | 58% | 0.186 |
Arm swelling | 42 | 28% | 12 | 24% | 22 | 44% | 8 | 16% | 0.006 |
Hair loss | 50 | 33% | 11 | 22% | 27 | 54% | 12 | 24% | 0.001 |
Low mood | 87 | 58% | 32 | 64% | 27 | 54% | 28 | 56% | 0.563 |
Other ** | 1 | 1% | 0 | 0% | 1 | 2% | 0 | 0% | 1 |
Secondary cancer site | |||||||||
First incidence | 131 | 87% | 44 | 88% | 40 | 80% | 47 | 94% | 0.001 |
Secondary incidence | 16 | 11% | 6 | 12% | 10 | 20% | 0 | 0% | |
No answer | 3 | 2% | 0 | 0% | 0 | 0% | 3 | 6% | |
T parameter | |||||||||
T0 | 4 | 3% | 2 | 4% | 1 | 2% | 1 | 2% | <0.001 |
T1 | 50 | 33% | 31 | 62% | 3 | 6% | 16 | 32% | |
T2 | 85 | 57% | 14 | 28% | 41 | 82% | 30 | 60% | |
T3 | 10 | 7% | 3 | 6% | 4 | 8% | 3 | 6% | |
T4 | 1 | 1% | 0 | 0% | 1 | 2% | 0 | 0% | |
N parameter | |||||||||
N0 | 96 | 64% | 37 | 74% | 20 | 40% | 39 | 78% | <0.001 |
N1 | 51 | 34% | 12 | 24% | 29 | 58% | 10 | 20% | |
N2 | 2 | 1% | 1 | 2% | 0 | 0% | 1 | 2% | |
N3 | 1 | 1% | 0 | 0% | 1 | 2% | 0 | 0% | |
M parameter | |||||||||
M0 | 146 | 97% | 49 | 98% | 48 | 96% | 49 | 98% | 0.073 |
M1 | 3 | 2% | 1 | 2% | 2 | 4% | 0 | 0% | |
M2 | 1 | 1% | 0 | 0% | 0 | 0% | 1 | 2% | |
Satisfaction with treatment | |||||||||
Yes | 99 | 66% | 42 | 84% | 21 | 42% | 36 | 72% | 0.001 |
Yes, moderately | 28 | 19% | 7 | 14% | 11 | 22% | 10 | 20% | |
Rather not | 14 | 9% | 1 | 2% | 12 | 24% | 1 | 2% | |
Not | 9 | 6% | 0 | 0% | 6 | 12% | 3 | 6% | |
Cosmetic result | <0.001 | ||||||||
Very good | 59 | 39% | 30 | 60% | 6 | 12% | 23 | 46% | |
Good | 68 | 45% | 18 | 36% | 28 | 56% | 22 | 44% | |
Poor | 17 | 11% | 2 | 4% | 12 | 24% | 3 | 6% | |
Very poor | 6 | 4% | 0 | 0% | 4 | 8% | 2 | 4% | |
Negative impact of treatment on personal life | |||||||||
Large impact | 53 | 35% | 12 | 24% | 31 | 62% | 10 | 20% | <0.001 |
Small impact | 46 | 31% | 20 | 40% | 10 | 20% | 16 | 32% | |
No impact | 51 | 34% | 18 | 36% | 9 | 18% | 24 | 48% | |
Time since the procedure was performed | |||||||||
Until the year | 29 | 19% | 10 | 20% | 5 | 10% | 14 | 28% | 0.209 |
1–2 years | 42 | 28% | 12 | 24% | 16 | 32% | 14 | 28% | |
Over 2 years | 79 | 53% | 28 | 56% | 29 | 58% | 22 | 44% |
Notes: *The total exceeds 100%, as the item allowed for multiple choices. **Leg swelling.